Aker BioMarine Toekomstige groei

Future criteriumcontroles 3/6

De omzet van Aker BioMarine zal naar verwachting dalen met 5.3% per jaar, terwijl de jaarlijkse winst naar verwachting zal groeien met 97.6% per jaar. De winst per aandeel zal naar verwachting groeien met 97.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 8.5% zijn.

Belangrijke informatie

97.6%

Groei van de winst

97.4%

Groei van de winst per aandeel

Food winstgroei33.2%
Inkomstengroei-5.3%
Toekomstig rendement op eigen vermogen8.5%
Dekking van analisten

Low

Laatst bijgewerkt22 Nov 2024

Recente toekomstige groei-updates

Recent updates

Aker BioMarine (OB:AKBM) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 08
Aker BioMarine (OB:AKBM) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors

Nov 05
Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors

At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Aug 20
At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

Jul 19
Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

Jul 16
What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Jul 11
There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

Jun 03
These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

Feb 15
There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Nov 06
There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

Sep 06
Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Nov 04
We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Apr 13
Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Feb 18
Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

Jan 07
Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

Winst- en omzetgroeiprognoses

OB:AKBM - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20262822223332
12/31/2025250129132
12/31/20242641-18-32
9/30/202433531452N/A
6/30/2024338-112669N/A
3/31/2024336-8651N/A
12/31/2023335-9-247N/A
9/30/2023227-15-2025N/A
6/30/20232420-415N/A
3/31/202326814-3512N/A
12/31/202227710-3115N/A
9/30/20222741-43-2N/A
6/30/202226810-279N/A
3/31/2022269-8-294N/A
12/31/2021262-8-783N/A
9/30/20212623-85-17N/A
6/30/2021270-8-139-63N/A
3/31/2021268-14-134-59N/A
12/31/2020289-5-75-51N/A
9/30/2020285-26-65-23N/A
6/30/2020284-28-1219N/A
3/31/2020278-18-333N/A
12/31/2019246-24-11512N/A
12/31/2018154-1-578N/A
12/31/2017126-18N/AN/AN/A
9/30/2017123-15N/AN/AN/A
6/30/2017122-11N/AN/AN/A
3/31/2017119-5N/AN/AN/A
12/31/2016117-2N/A21N/A
9/30/2016111-8N/AN/AN/A
6/30/20161100N/AN/AN/A
3/31/2016109-3N/AN/AN/A
12/31/20151051N/A18N/A
9/30/2015105-5N/AN/AN/A
6/30/2015103-14N/AN/AN/A
3/31/2015111-13N/AN/AN/A
12/31/2014112-17N/A-11N/A
9/30/201499-34N/AN/AN/A
6/30/201410944N/AN/AN/A
3/31/201410643N/AN/AN/A
12/31/201310947N/AN/AN/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei AKBM ( 97.6% per jaar) ligt boven de spaarquote ( 2.4% ).

Winst versus markt: De winst van AKBM ( 97.6% per jaar) zal naar verwachting sneller groeien dan de Norwegian markt ( 9.5% per jaar).

Hoge groeiwinsten: De winst van AKBM zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van AKBM zal naar verwachting de komende 3 jaar dalen ( -5.3% per jaar).

Hoge groei-inkomsten: De omzet van AKBM zal naar verwachting de komende 3 jaar dalen ( -5.3% per jaar).


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen AKBM zal naar verwachting over 3 jaar laag zijn ( 8.5 %).


Ontdek groeibedrijven